Contrivance - a major cause for failure of aerosol therapy in childhood

M. L. Everard, V. Brennan (Sheffield, United Kingdom)

Source: Annual Congress 2002 - Updates of inhalation therapy in children
Session: Updates of inhalation therapy in children
Session type: Poster Discussion
Number: 2724
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. L. Everard, V. Brennan (Sheffield, United Kingdom). Contrivance - a major cause for failure of aerosol therapy in childhood. Eur Respir J 2002; 20: Suppl. 38, 2724

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Critical illness polineuropathy as a cause of difficult weaning in stable patients with chronic respiratory failure: effect of rehabilitation
Source: Eur Respir J 2002; 20: Suppl. 38, 265s
Year: 2002

Long-term respiratory consequences of childhood cancer and its treatment
Source: ISSN=1025-448x, ISBN=1-904097-22-7, page=267
Year: 2002

Acute exacerbation of interstitial lung diseases as a cause of respiratory failure. Our 3-years experience
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010

Influenza viruses as etiologic agents of the acute respiratory infections in infancy and early childhood - is their role underestimated?
Source: Eur Respir J 2002; 20: Suppl. 38, 176s
Year: 2002

Acute effects of early mobility and respiratory therapy in hospitalised patients with chronic heart failure
Source: Annual Congress 2009 - Respiratory physiotherapy assessment
Year: 2009


Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy
Source: Guideline 2007
Year: 2007

Successful use of a ²bottom up² strategy to reduce acute asthma morbidity during childhood
Source: Eur Respir J 2006; 28: Suppl. 50, 481s
Year: 2006

Possible risk factors for early and late NIV failure
Source: International Congress 2016 – New insights into noninvasive ventilation: between the dream and reality
Year: 2016

Preventing clinically important deterioration with single-inhaler triple therapy in COPD
Source: ERJ Open Res, 4 (4) 00047-2018; 10.1183/23120541.00047-2018
Year: 2018



The main causes which lead to immediate and belated failure in tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 141s
Year: 2005

Late Breaking Abstract - Severe pneumonia patients may could not benefit from antibiotic combination therapy and non-invasive ventilation(NIV), despite the advanced mode
Source: International Congress 2018 – Non-invasive ventilation for acute respiratory failure
Year: 2018


Do childhood respiratory infections continue to influence adult respiratory morbidity?
Source: Eur Respir J 2009; 33: 237-244
Year: 2009



Bronchial asthma is not a common cause of severe chronic respiratory failure in non-smokers: ALOT study
Source: Eur Respir J 2004; 24: Suppl. 48, 260s
Year: 2004

Which are the factors and causes that lead to omalizumab withdrawal in severe asthma patients?
Source: International Congress 2018 – New developments in the treatment of asthma
Year: 2018

School children as change agent for early diagnosis, treatment and prevention of respiratory illness and diseases
Source: Virtual Congress 2020 – Pulmonary function and rehabilitation in non-respiratory disease
Year: 2020

Anti-IL5 therapy could prevent lung function decline in severe eosinophilic asthma: data from the belgian severe asthma registry
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Year: 2021


The characteristics of treatment failure with omalizumab in patients with severe asthma: The impact of eosinophilic complication
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020